p53 specific sequence and control shRNAs were obtained from Addgene (Cambridge, MA, USA). Lentiviral particles were produced using the second-generation packaging system obtained from Addgene as reported previously41. In short, 10 μg of p53 or control shRNA plasmid, 7.5 μgs of packaging plasmid (psPAX2 plasmid) and 2.5 μg of envelope plasmid (pMD2.G plasmid) were transfected in HEK293t cells using FUGENE 6 (Promega, Fitchburg, WI, USA) transfection reagent according to manufacturer’s instructions. Medium was replaced 24 hrs following transfection. Two days later, lentivirus containing medium was collected and concentrated using Lenti-x concentrator (Takara Bio, Mountain View, CA, USA). Lentivirus particles were re-suspended in OPTI-MEM (Life Technologies), aliquoted and stored in −80 °C for later use. 253G1 human iPS cells were transduced with lentiviral particles using 6 μg/ml polybrene (San Cruz Biotech). When confluent, transduced cells were passaged and expanded. Successfully transduced cells were selected using 2 μg/ml puromycin and were used for experiments.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.